| Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ... The Lancet 395 (10241), 1907-1918, 2020 | 1952 | 2020 |
| TROPHY-U-01: a phase II open-label study of sacituzumab govitecan in patients with metastatic urothelial carcinoma progressing after platinum-based chemotherapy and checkpoint … ST Tagawa, AV Balar, DP Petrylak, AR Kalebasty, Y Loriot, A Fléchon, ... Journal of Clinical Oncology 39 (22), 2474-2485, 2021 | 446 | 2021 |
| Computerized classification of intraductal breast lesions using histopathological images MM Dundar, S Badve, G Bilgin, V Raykar, R Jain, O Sertel, MN Gurcan IEEE Transactions on Biomedical Engineering 58 (7), 1977-1984, 2011 | 253 | 2011 |
| Prognostic impact of ALDH1 in breast cancer: a story of stem cells and tumor microenvironment E Resetkova, JS Reis-Filho, RK Jain, R Mehta, MA Thorat, H Nakshatri, ... Breast cancer research and treatment 123, 97-108, 2010 | 225 | 2010 |
| Cabozantinib in advanced non-clear-cell renal cell carcinoma: a multicentre, retrospective, cohort study NM Chanzá, W Xie, MA Bilen, H Dzimitrowicz, J Burkart, DM Geynisman, ... The lancet oncology 20 (4), 581-590, 2019 | 167 | 2019 |
| FOXA1 is an independent prognostic marker for ER-positive breast cancer RJ Mehta, RK Jain, S Leung, J Choo, T Nielsen, D Huntsman, H Nakshatri, ... Breast cancer research and treatment 131, 881-890, 2012 | 165 | 2012 |
| Atypical ductal hyperplasia: interobserver and intraobserver variability RK Jain, R Mehta, R Dimitrov, LG Larsson, PM Musto, KB Hodges, ... Modern Pathology 24 (7), 917-923, 2011 | 144 | 2011 |
| Hepatocyte dysfunction and hepatic encephalopathy in Plasmodium falciparum malaria DK Kochar, P Agarwal, SK Kochar, R Jain, N Rawat, RK Pokharna, ... Qjm 96 (7), 505-512, 2003 | 133 | 2003 |
| High‐level expression of forkhead‐box protein A1 in metastatic prostate cancer RK Jain, RJ Mehta, H Nakshatri, MT Idrees, SS Badve Histopathology 58 (5), 766-772, 2011 | 89 | 2011 |
| Efficacy and safety of telaglenastat plus cabozantinib vs placebo plus cabozantinib in patients with advanced renal cell carcinoma: the CANTATA randomized clinical trial NM Tannir, N Agarwal, C Porta, NJ Lawrence, R Motzer, B McGregor, ... JAMA oncology 8 (10), 1411-1418, 2022 | 87 | 2022 |
| A coupled numerical and artificial neural network model for improving location specific wave forecast SN Londhe, S Shah, PR Dixit, TMB Nair, P Sirisha, R Jain Applied Ocean Research 59, 483-491, 2016 | 82 | 2016 |
| Extrathoracic metastases of thymic origin: a review of 35 cases T Vladislav, RK Jain, R Alvarez, RJ Mehta, Y Gökmen-Polar, KA Kesler, ... Modern Pathology 25 (3), 370-377, 2012 | 82 | 2012 |
| Changing trends of antimicrobial susceptibility patterns of Neisseria gonorrhoeae in India and the emergence of ceftriaxone less susceptible N. gonorrhoeae strains M Bala, K Ray, SM Gupta, S Muralidhar, RK Jain Journal of Antimicrobial Chemotherapy 60 (3), 582-586, 2007 | 82 | 2007 |
| Safety and efficacy of nivolumab in patients with advanced non–clear cell renal cell carcinoma: results from the phase IIIb/IV CheckMate 374 study NJ Vogelzang, MR Olsen, JJ McFarlane, E Arrowsmith, TM Bauer, ... Clinical genitourinary cancer 18 (6), 461-468. e3, 2020 | 80 | 2020 |
| Cancer survivorship and models of survivorship care: a review KD Miller, M Pandey, R Jain, R Mehta American Journal of Clinical Oncology 38 (6), 627-633, 2015 | 74 | 2015 |
| A single-arm, multicenter, phase 2 study of lenvatinib plus everolimus in patients with advanced non-clear cell renal cell carcinoma TE Hutson, MD Michaelson, TM Kuzel, N Agarwal, AM Molina, JJ Hsieh, ... European urology 80 (2), 162-170, 2021 | 73 | 2021 |
| Expression of Forkhead-box protein A1, a marker of luminal A type breast cancer, parallels low Oncotype DX 21-gene recurrence scores FO Ademuyiwa, MA Thorat, RK Jain, H Nakshatri, S Badve Modern Pathology 23 (2), 270-275, 2010 | 63 | 2010 |
| A multiple instance learning approach toward optimal classification of pathology slides MM Dundar, S Badve, VC Raykar, RK Jain, O Sertel, MN Gurcan 2010 20th International Conference on Pattern Recognition, 2732-2735, 2010 | 58 | 2010 |
| WHO types A and AB thymomas: not always benign RK Jain, RJ Mehta, JD Henley, KA Kesler, PJ Loehrer, S Badve Modern Pathology 23 (12), 1641-1649, 2010 | 56 | 2010 |
| Status report on production, processing and marketing of betel leaf (Piper betle L.) P Guha, RK Jain Agricultural and Food Engineering Department, IIT, Kharagpur, India, 15-22, 1997 | 52 | 1997 |
Rutika MehtaH. Lee Moffitt Cancer CenterE-mail megerősítve itt: moffitt.org